Clinical Trial Update: Single Arm Clinical Trial (Gut Microbiota and HCC) [Phase 2]

View source ↗

Summary

Phase 2 single-arm clinical trial investigating the relationship between gut microbiota and hepatocellular carcinoma. The study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Xu Yong, MD | Conditions: Liver Cancer | Phase 2 | Status: NOT_YET_RECRUITING